Your browser doesn't support javascript.
loading
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
Saad, Fred; Thiery-Vuillemin, Antoine; Wiechno, Pawel; Alekseev, Boris; Sala, Nuria; Jones, Robert; Kocak, Ivo; Chiuri, Vincenzo Emanuele; Jassem, Jacek; Fléchon, Aude; Redfern, Charles; Kang, Jinyu; Burgents, Joseph; Gresty, Christopher; Degboe, Arnold; Clarke, Noel W.
  • Saad F; Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. Electronic address: fredsaad@videotron.ca.
  • Thiery-Vuillemin A; Department of Medical Oncology, Centre Hospitalier Universitaire Besançon, Besançon, France.
  • Wiechno P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Alekseev B; Hertzen Moscow Cancer Research Institute, Moscow, Russia.
  • Sala N; Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain.
  • Jones R; Velindre Cancer Centre, Cardiff University, Cardiff, UK.
  • Kocak I; Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Chiuri VE; Ospedale Vito Fazzi, Lecce, Italy.
  • Jassem J; Medical University of Gdansk, Gdansk, Poland.
  • Fléchon A; Centre Léon Bérard, Lyon, France.
  • Redfern C; Sharp HealthCare, San Diego, CA, USA.
  • Kang J; AstraZeneca, Gaithersburg, MD, USA.
  • Burgents J; Merck & Co, Rahway, NJ, USA.
  • Gresty C; AstraZeneca, Cambridge, UK.
  • Degboe A; AstraZeneca, Gaithersburg, MD, USA.
  • Clarke NW; The Christie and Salford Royal Hospitals, Manchester, UK.
Lancet Oncol ; 23(10): 1297-1307, 2022 10.
Article en En | MEDLINE | ID: mdl-36063830
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno Prostático Específico / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno Prostático Específico / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article